Delisted

Stopped trading. Fund positions aren't valued until we confirm what happened.

RVNC

REVANCE THERAPEUTICS INC

RVNC·761330109·US·Common Stock-13D/G

RVNC (REVANCE THERAPEUTICS INC) is held by 0 institutional investors as of Q1 2025.

0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly

No verdict yet — fewer than 2 funds hold RVNC.

Top Holders

Checking access…
Action
Exited
0(-100.0%)$36,7570.0%—
0
Exited
0(-100.0%)$1.3M0.0%—
0
Exited
0(-100.0%)$282,3550.0%—
0
Exited
0(-100.0%)$3040.0%—
0
Exited
0(-100.0%)$10.6M0.0%—
0
Exited
0(-100.0%)$3M0.0%—
0
Exited
0(-100.0%)$9.6M0.0%—
0
Exited
0(-100.0%)$95,2680.0%—
0
Exited
0(-100.0%)$64,0680.0%—
0
Exited
0(-100.0%)$177,2410.0%—
0
Exited
0(-100.0%)$7.8M0.0%—
0
Exited
0(-100.0%)$276,9990.0%—
0
Exited
0(-100.0%)$583,9930.0%—
0
Exited
0(-100.0%)$72,0660.0%—
0
Exited
0(-100.0%)$87,3180.0%—
0
Exited
0(-100.0%)$72,4460.0%—
0
Exited
0(-100.0%)$909,0790.0%—
0
Exited
0(-100.0%)$343,9760.0%—
0
Exited
0(-100.0%)$64,1090.0%—
0
Exited
0(-100.0%)$892,7730.0%—
0

Showing 1-20 of 100

1 / 5
RVNCRVNCREVANCE THERAPEUTICS INC

Similar stocks

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used